Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cempra
Biotech
Melinta merges with faltering Cempra
The agreement brings together two of the biotechs plugging away, with mixed success, at late-phase development of anti-infective drugs.
Nick Paul Taylor
Aug 9, 2017 9:56am
EuroBiotech Report: Brexit, Novartis, IQWiG-EMA, antibiotics and Cempra
Mar 30, 2017 11:12am
Cempra pulls EU antibiotic filing following EMA questioning
Mar 28, 2017 7:51am
Another setback for Cempra’s solithromycin, this time in gonorrhea
Feb 28, 2017 7:58am
FDA delays Cempra antibiotic over manufacturing, safety issues
Dec 29, 2016 7:25am
FDA panel, by a whisker, votes yes on Cempra’s antibiotic
Nov 7, 2016 4:13am